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Abstract
Treatment for peripheral nerve injuries includes the use of autografts and nerve
guide conduits (NGCs). However, outcomes are limited, and full recovery is rarely
achieved. The use of nerve scaffolds as a platform to surface immobilize neuro-
trophic factors and deliver locally is a promising approach to support neurite and
nerve outgrowth after injury. We report on a bioactive surface using functional
amine groups, to which heparin binds electrostatically. X‐ray photoelectron spec-
troscopy analysis was used to characterize the presence of nitrogen and sulfur.
Nerve growth factor (NGF) and brain‐derived neurotrophic factor (BDNF) were
bound by electrostatic interaction to heparin, and the release profile evaluated by
enzyme‐linked immunosorbent assay, which showed that ca. 1% of NGF was re-
leased from each of the bioactive surface within 7 days. Furthermore, each surface
showed a maximum release of 97% of BDNF. Neurotrophin release on neurite
outgrowth was evaluated by primary dorsal root ganglion with a maximum neurite
growth response in vitro of 1,075 µm detected for surfaces immobilized with NGF at
1 ng/ml. In summary, the study reports on the design and construction of a biomi-
metic platform to deliver NGF and BDNF using physiologically low concentrations of
neurotrophin. The platform is directly applicable and scalable for improving the
regenerative ability of existing NGCs and scaffolds.
K E YWORD S
bioactive surface, brain‐derived neurotrophic factor, nerve growth factor, nerve repair, neurite
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1 | INTRODUCTION
Peripheral nerve injury is a major cause of disability, affecting 1 in
1,000 patients (Hughes, 2008). Injuries drastically affect life quality
and health due to decreased sensory and motor function (Daly, Yao,
Zeugolis, Windebank, & Pandit, 2012; Lundborg, 2003; Pateman
et al., 2015). Self‐regeneration may occur if the injury is not severe.
However, as the degree of injury increases, recovery of sensory and
motor function is often incomplete (Hu, Tian, Prabhakaran, Ding, &
Ramakrishna, 2016; Mcgregor & English, 2019). Autografting is a
standard clinical approach to treat regeneration of completely
transected nerves. Other approaches include end‐to end or end‐to‐
side suturing, allografting, and the use of nerve guide conduits
(NGCs; Behbehani et al., 2018; Bell & Haycock, 2012; Grinsell &
Keating, 2014; Johnson, Zoubos, & Soucacos, 2005; Pateman
et al., 2015). Irrespectively, each of these treatments has limitations
and drawbacks that do not support sufficient peripheral nerve re-
generation. Research has been conducted to improve the performance
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of NGCs, and more recently, focus on the architectural structures
within a device to increase trophic support, the addition of neuro-
trophic factors, and/or cell therapy (Catrina, Gander, & Madduri, 2013;
Madduri, Feldman, Tervoort, Papaloïzos, & Gander, 2010). Neuro-
trophic factors support neural regeneration and survival (Madduri,
Papaloïzos, & Gander, 2009; Önger et al., 2016), and well‐described
factors include nerve growth factor (NGF), brain‐derived neurotrophic
factor (BDNF), glial cell‐derived neurotrophic factor (GDNF), and
ciliary neurotrophic factor (CNTF; Deister & Schmidt, 2006; Dinis
et al., 2015; Fadia et al., 2020; Fine, Decosterd, Papaloïzos, Zurn, &
Aebischer, 2002; Madduri et al., 2009). NGF is known to stimulate
neurite growth and neural survival after injury (Hu et al., 2016; Zhao
et al., 2016), whereas BDNF promotes neuronal survival and
morphogenesis (Numakawa et al., 2010). Moreover, GDNF encourages
neurite outgrowth and decreases neuronal apoptosis (Fadia
et al., 2020; Fine et al., 2002), and CNTF stimulates the remyelination
of regenerated neurites (Dinis et al., 2015).
Although neurotrophic factors have previously been introduced
into NGCs, nerve repair has not been stimulated significantly, due
largely to a short half‐life (e.g., 2.3 hr NGF [rat] and 3 hr BDNF [rat];
Kishino et al., 2001; Tria, Fusco, Vantini, & Mariot, 1994), with pro-
teolytic degradation and lack of diffusion due to initial single delivery
(Lee, Silva, & Mooney, 2011; Tang et al., 2013). Moreover, the re-
generation process in large injury gaps (>10mm) occurs over weeks.
Hence, for NGC functionality, it is important to design a sustained
delivery system for neurotrophic factors (Achyuta, Cieri, Unger, &
Murthy, 2009; Gomez & Schmidt, 2007). Electrochemistry, micro-
fluidics, lithography, and microspheres have been used to immobilize
neurotrophins in different delivery systems, including NGCs. These
techniques can be disadvantageous, because they require complex
experimental design and fabrication, leading to long preparation
periods, limiting clinical application (Tang et al., 2013) and effec-
tiveness on nerve regeneration (Madduri et al., 2010; Moran &
Graeber, 2004; Sumner, 1990; Tang et al., 2013). Alternatively, de-
velopment of bioactive surfaces in direct contact with regenerating
axons will target the delivery of neurotrophic factors more precisely,
with direct stimulation for neurite outgrowth.
Biomaterial surfaces are essential for interaction with the en-
vironment (Ratner, 2013), and several approaches exist to stimulate
biological response (Jones, 2005). Bioactive surfaces as a delivery
platform have advantages of controlled, targeted delivery, sustained
release, and low dosage. A range of examples are reported, for ex-
ample, Puleo, Kissling, and Sheu (2002) immobilized bone morpho-
genetic protein onto titanium alloy to promote osteoblastic activity.
Ito, Chen, and Imanishi (1998) encouraged fibroblast growth by im-
mobilizing epidermal growth factor onto polystyrene.
We have developed a glycosaminoglycan surface platform for
growth factor delivery using heparin, through transient charge at-
traction of negative functional groups and local release (WO 2017/
017425 A1, 2017). For this particular study, we employed a com-
mercial source of amine functionalized surfaces that arose directly
from this prior study (Robinson et al., 2012). As a method to permit
charge attraction, positive surface amine functional groups (NH2
+)
are created as a basis to attract and bind negatively charged heparin
by adsorption to a biomaterial surface of interest (Cao & Li, 2011).
We have not previously explored this system for neurotrophin
binding and release; however, it is reported that neurotrophins bind
to heparin (Casu, Naggi, & Torri, 2015; D. Yang, Moon, & Lee, 2017).
The advantage of this method is that it would build the necessary
electrostatic positive charge to immobilize neurotrophins, by means
of electrostatic interactions between NH2
+ groups and negatively
charged heparin, and by the heparin binding site of neurotrophins.
Investigation of a neurotrophin delivery platform is logical to explore
for neurite outgrowth by the immobilized of NGFs onto NH2
+ +
heparin surfaces for local and sustained release.
The aim of this study was, therefore, to create experimental
bioactive surfaces comprising NH2
+ and heparin to which im-
mobilized NGF, BDNF, or a combination of both could be constructed
for release, and neuronal cell response. Herein we report on the
design and construction of the system by passive conjugation of
heparin and neurotrophic factors. Using primary chick embryo dorsal
root ganglion (DRG), enhanced neurite outgrowth was observed
when cultured on neurotrophin‐enriched surfaces compared to
control surfaces tissue culture plastic (TCP), NH2
+, and NH2
+ +
heparin with soluble growth factors.
2 | MATERIALS AND METHODS
2.1 | Heparin adsorption to amine functional
surfaces
Ninety‐six‐well plates treated by amine plasma polymerization (Robinson
et al., 2012) were sourced (BD PureCoat™; Becton Dickinson, Belgium).
A solution of heparin sodium salt from porcine intestinal mucosa (Sigma,
UK) was prepared at a concentration of 50 µg/ml. The heparin was ad-
ded to the BD PureCoat™ plates and left overnight at room temperature
(RT). The heparin solution was then poured off and discarded.
2.2 | Immobilization of NGF and BDNF to
amine–heparin surfaces
NGF (R&D Systems), BDNF (R&D Systems), and combinations of the
two were immobilized onto the amine–heparin surfaces. Different
concentrations of NGF, BDNF, and NGF plus BDNF were prepared at
concentrations of 1 pg/ml, 1 ng/ml, 10 ng/ml, 100 ng/ml, and 1 µg/ml.
Each solution was added to the amine–heparin surface and incubated
for 5 hr at RT, poured off, and discarded. Figure 1 summarizes the
design of surfaces immobilized with amine–heparin–neurotrophin.
2.3 | Water contact angle
Water contact angle was measured with a Krüss GmbH drop shape
analyzer‐100 (DSA100) by placing 5 μl of distilled water on the test
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surface. The contact angle of surfaces was measured and calculated
using DSA100 software.
2.4 | X‐ray photoelectron spectroscopy
X‐ray photoelectron spectroscopy (XPS) analysis was performed on
surfaces at the Sheffield Surface Analysis Centre (The University of
Sheffield, UK). Elemental composition (survey scans), nitrogen scans
(N1s), and sulfur scans (S2p) were conducted using a Kratos Ultra
with a monochromated aluminum source. Elemental survey scans
were collected between 0 and 1,200 eV binding energy, and at
160 eV pass energy. N1s and S2p spectra were collected for samples
containing amine and heparin, at 20 eV pass energy.
2.5 | Release profile of NGF and BDNF from
amine–heparin surfaces
In vitro release of NGF and BDNF was tested by incubating im-
mobilized surfaces with 1ml of phosphate‐buffered saline (PBS) at
37°C. Solution samples were taken at 1, 24, 48, and 168 hr and
measured with enzyme‐linked immunosorbent assay (ELISA; Yan, Yin,
& Li, 2012; Zeng et al., 2014). Briefly, control and test solutions were
added to wells and incubated at RT for 2.5 hr, then they were dis-
carded and the plate was rinsed with washing buffer. Biotinylated
antibody was added to the wells and incubated for 1 hr at RT. The
plate was then rinsed and streptavidin‐horseradish peroxidase added
for 45min at RT. 3,3′,5,5′‐tetramethylbenzidine substrate was added
and incubated for 30min at RT, followed by stop solution. Absor-
bance was read at 450 nm using a Bio‐Tek ELx 800 microplate reader
and KC Junior software.
2.6 | In vitro study using chick embryonic dorsal
root ganglia
To evaluate neurotrophin surfaces, embryonic chick DRGs were
utilized. Fertilized brown chicken eggs (Henry Stewart & Co. Ltd., UK)
were incubated at 37.5°C and 50–70% humidity for 12 days. Em-
bryonic day 12 eggs were opened in a biological safety cabinet to
collect the E12 embryo, which was cleaned, and organs were re-
moved (in compliance with UK Home Office Animals [Scientific
Procedures] Act 1986 and definition of chicken as a Protected
Animal from E14). DRGs were dissected and under a dissecting mi-
croscope, the remains of the root were cut (Powell, Vinod, & Lem-
ons, 2014). DRGs were seeded at a density of one per well on TCP
and on bioactive surfaces, with Dulbecco's modified Eagle's medium
(DMEM; Sigma) plus 10% (v/v) fetal bovine serum (PAN Biotech,
Germany), 1% (w/v) L‐glutamine (Sigma), 1% (w/v) penicillin/strep-
tomycin (P/S; Sigma), 0.25% (w/v) amphotericin B (Sigma), and NGF,
BDNF, or NGF plus BDNF at the above concentrations. DMEM
supplemented with 10% (v/v) fetal calf serum, 1% (w/v) L‐glutamine,
1% (w/v) P/S, and 0.25% (w/v) amphotericin was added to samples
and DRGs were cultured for 7 days at 37°C and 5% CO2.
2.7 | Identification of chick DRG neurite growth by
βIII‐tubulin immunolabelling
Immunolabelling was performed for βIII‐tubulin to identify neurons
and measure neurite outgrowth. To label cell nuclei, 4′,6‐diamidino‐2‐
phenylindole (DAPI, 300 nM; Sigma) was used. Culture medium was
discarded from samples and 3.7% (w/v) paraformaldehyde (PFA) was
added and incubated for 30min at RT. PFA was discarded and
samples were rinsed three times with PBS (Oxoid, England). Triton X‐
100 (0.1%; Sigma) with 3% (w/v) bovine serum albumin (BSA; Sigma)
in PBS was added and incubated for 1 hr at RT and was then dis-
carded and washed three times. Anti‐βIII‐tubulin primary antibody
(1:1,000; Abcam, UK) in 1% (w/v) BSA/PBS was added and incubated
overnight at 4°C, then removed. Alexa Fluor‐488 goat anti‐mouse
secondary antibody (1:400; Life Technologies) in 1% BSA (w/v) in PBS
was added to samples and incubated for 3 hr at RT. Samples were
then washed three times with PBS. Three hundred nanomole DAPI in
PBS was added and incubated for 30min at RT, then discarded and
washed three times with PBS.
2.8 | Epifluorescence microscopy
Whole DRG and neurites were imaged using an inverted Olympus
IX73 epifluorescent microscope and Micro‐Manager 1.4.22 software
(University of California). A mercury lamp was used as the light
source. To image βIII‐tubulin positive neurites (Alexa Fluor‐488) and
nuclei (DAPI), excitation and emission wavelengths of λex = 488 nm/
λem = 525 nm and λex = 405 nm/λem = 450 nm were used, respectively.
ImageJ 1.52a (National Institutes of Health) was used to measure the
length of developed neurites. Neurites were measured from the DRG
F IGURE 1 Design and construction of a biomimetic surface for assisting neuronal growth. (a) NH2
+ surface. (b) Water droplet angle when in
contact with NH2
+ surface (43°). (c) X‐ray photoelectron spectroscopy (XPS) scan of NH2
+ surface with nitrogen peak visible at 400 eV. (d)
Heparin added to NH2
+ surface with electrostatic binding. (e) NH2
+ + heparin surface. (f) Water droplet angle when in contact with
NH2
+ + heparin surface (39°). (g) XPS scan of NH2
+ + heparin surface confirming sulfur at 168 eV. (h) Nerve growth factor (NGF) and/or brain‐
derived neurotrophic factor (BDNF) added to the NH2
+ + heparin surface. (i) Surface immobilized with NGF and/or BDNF. (j) NGF release profile
from the loaded surface within 168 hr. (k) BDNF release profile from loaded surface within 168 hr. Adaptation from Paoletti et al. (2016) and
Robinson et al. (1999) [Color figure can be viewed at wileyonlinelibrary.com]
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to the tip of the neurite. The experiment was repeated three times
independently (N = 3). Each repeat had three DRGs per condition
(n = 3). Three images were taken, one per DRG, and 10–15 neurites
were measured, per condition, to determine the mean of neurite
outgrowth. Background was subtracted (20–30 pixels) to enhance
intensity and contrast.
2.9 | Statistical analysis
One‐way analysis of variance with a Tukey multiple comparison
posttest was performed to identify statistical differences between
conditions, using GraphPad Prism 8.2.0. p < .05 was considered
significant.
3 | RESULTS
3.1 | Characterization of surfaces by water contact
angle
Water contact angles were measured by sessile drop as a measure of
relative hydrophilicity (Liu et al., 2014). The mean contact angles of
polystyrene (PS), TCP, TCP +NH2
+, and TCP +NH2
+ + heparin were
98, 70, 43, and 39°, respectively (Figure 2). The decrease in the
contact angle confirmed the presence of charged functional groups at
the surface, such as amine (NH2
+) and sulfate. The lowest contact
angle was observed for TCP + NH2
+ + heparin. PS control angles were
significantly different compared to TCP +NH2
+ and TCP +NH2
+ +
heparin surfaces (****p < .0001). TCP angles were also significantly
different when compared with TCP +NH2
+ and TCP +NH2
+ + heparin
surfaces (***p < .001 and ****p < .0001, respectively). There was no
difference between the contact angles for TCP +NH2
+ and
TCP +NH2
+ + heparin.
3.2 | Characterization surfaces by XPS
XPS analysis was used to determine elemental composition of sur-
faces after each modification step. Chemical survey scans of each are
shown in Figure 1. TCP +NH2
+ surfaces and TCP +NH2
+ + heparin
surfaces identified a peak at 400 eV, confirming the presence of ni-
trogen with 12.6% and 9.15% of atomic composition (Figure 1c
and 1g and Figure S1A). Furthermore, N1s scan revealed a single
peak, which was attributed to the NH2
+ content on the TCP +NH2
+
surface and TCP +NH2
+ + heparin surface (Figure S1B and S1C), as
TCP has a negligible nitrogen content (Koller, Palsson, Manchel,
Maher, & Palsson, 1998). Moreover, the decreased nitrogen content
in the TCP +NH2
+ + heparin surface could possibly be due to the loss
of nitrogen after the incubation step of heparin, during the rinsing
step (Dehili, Lee, Shakesheff, & Alexander, 2006). An S2p peak was
detected for the TCP +NH2
+ + heparin surface at 168 eV (Figure 1g).
Figure S1D shows the S2p scan with S2p3/2 and S2p1/2. This con-
firmed the presence of sulfur, and hence heparin.
3.3 | Release of NGF and BDNF from
NH2
+ + heparin surfaces
NGF release from NH2
+ + heparin surfaces was measured over
168 hr by ELISA (Figure 1j and Table 1). None of the surfaces
immobilized with NGF, at any of the used concentrations, released
NGF within 1 hr. For surfaces immobilized with NGF at 1 µg/ml,
0.03% of the total dose was detected at 24 hr. For surfaces im-
mobilized with NGF at 100 ng/ml, 1% (24 hr) and 0.04% (48 hr)
were detected, respectively. NGF release was quantified at 24 and
48 hr for surfaces immobilized with 10 ng/ml, with 1% and 0.06%
of total load detected, respectively. Surfaces immobilized with
NGF at the lower concentration of 1 ng/ml did not show growth
factor release at 24 or 48 hr; however, at 168 hr, 1% of NGF was
detected. Quantification of BDNF released from surfaces was
evaluated over 168 hr by ELISA (Figure 1k and Table 1). For
surfaces immobilized with BDNF at 1 µg/ml, 3% and 0.01% of the
total dose was measured at 1 and 24 hr. Moreover, 0.06% and
0.01% was measured after 48 and 168 hr, respectively. For sur-
faces immobilized with BDNF at 100 ng/ml, 32% (1 hr), 0.18%
(24 hr), 0.37% (48 hr), and 0.17% (168 hr) of initial load was
detected, respectively. BDNF was quantified at 1, 24, 48, and
168 hr for surfaces immobilized with 10 ng/ml, resulting in 35%,
2.8%, 1.2%, and 1.5% of initial load, respectively. Surfaces
immobilized with BDNF at 1 ng/ml showed 25%, 30%, 11%, and
31% of growth factor release at 1, 24, 48, and 168 hr.
F IGURE 2 Water contact angle for each surface (±SD).
Polystyrene (98°), tissue culture polystyrene (TCP; 70°), TCP +NH2
+
(TCP + amine functionalized surface; 43°), and TCP +NH2
+ + heparin;
39°) surfaces. (N = 3 and n = 3). One‐way analysis of variance
(ANOVA) with Tukey multiple comparison test was performed.
****p < .0001 and ***p < .001
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3.4 | Chick dorsal root ganglion neurite outgrowth
Normal chick primary DRGs were cultured on surfaces immobilized
with concentrations of NGF, BDNF, and NGF + BDNF from 1 pg/ml to
1 µg/ml. Figure 3 shows average neurite length developed by the
DRGs after 7 days in culture. Neurite outgrowth was significantly
increased for DRGs grown on surfaces immobilized with NGF at
1 ng/ml, in comparison with control surfaces of TCP, NH2
+ alone, and
NH2
+ + heparin alone. Moreover, neurite outgrowth from surfaces
immobilized with NGF, BDNF, and NGF plus BDNF were longer than
neurites developed on the control surfaces of TCP, NH2
+ alone, and
NH2
+ + heparin alone (Figure 3d). As seen in Figure 3a, DRG neurites
were longest when grown on surfaces immobilized with NGF at
1 ng/ml. Neurite lengths were less when grown on NGF surfaces of
10 ng/ml and 1 µg/ml. A similar response was observed for neurite
outgrowth with immobilized BDNF (Figure 3b). Longest neurite
development was observed when DRGs were cultured on BDNF
surfaces at 1 ng/ml. When DRGs were cultured on surfaces im-
mobilized with NGF plus BDNF (Figure 3c), neurite outgrowth was
longest for 100‐ng/ml surfaces. These results demonstrate that im-
mobilizing neurotrophic factors either as NGF, BDNF, or a combi-
nation of both can support neurite growth. Immobilized NGF had a
more positive effect, compared to immobilized BDNF. Immobilization
of NGF plus BDNF did not have an additive effect compared to either
neurotrophin alone on neurite length (except at 1 pg/ml).
4 | DISCUSSION
NGF and BDNF were immobilized at different concentrations on
surfaces comprising NH2
+ + heparin to form a biomaterial substrate
optimal for enhancing neurite outgrowth. Culture of primary chick
DRGs isolated at E12 were used to evaluate neurotrophin functio-
nalized surfaces. Studies have previously investigated NGF, BDNF,
and GDNF in conjunction with scaffolds and nerve guide tubes, and
evaluated neurite expression (Achyuta et al., 2009; Gomez &
Schmidt, 2007; Kapur & Shoichet, 2004; Madduri et al., 2010; Santos,
Gonzalez‐Perez, Navarro, & Del Valle, 2016; Tang et al., 2013). In
these studies, neurotrophins were associated with biomaterial sur-
faces using different approaches. Interestingly, the concentration of
neurotrophin required was higher than those used in the present
study. Gomez and Schmidt (2007) immobilized NGF at 1 ng/mm2 on
polypyrrole by a photochemical technique with average neurite
lengths of 20 µm after 2 days of rat DRG culture. Tang et al. (2013)
used a silk fibroin coating to immobilize NGF as a gradient on poly(ɛ‐
caprolactone)‐poly(L‐lactic) acid. The cumulative release of NGF
ranged from 3.6 to 11.35 ng/ml within 7 days. Neurite lengths of
DRGs after 3 days in culture varied according to the gradient zone,
from 600 to 1,500 µm (Tang et al., 2013). In contrast, surfaces cre-
ated herein formed a platform to deliver immobilized neurotrophins
after 7 days release using less than 1 ng/ml from 1 to 168 hr. Max-
imum average neurite length of 1,075 µm was observed when sur-
faces were immobilized with NGF at 1 ng/ml. This suggests that
neurotrophin delivery is more efficient by using growth factors at
less than 1 ng/ml for stimulating neurite lengths greater than
1,000 µm in vitro.
Evidence in support of functional surface characterization in-
cluded water contact angle, initially conducted to evaluate relative
wettability of the modified material. Surface wettability will change
due to the presence of positively charged amine groups (Li, Li, Yu, &
Sun, 2017) or negatively charged heparin (Cao & Li, 2011; Mascotti &
Lohman, 1995; T. Yang et al., 2006). Results showed a decrease in
contact angle, leading to an increase in hydrophilicity. Changes in
contact angle and relative wettability of modified surfaces ranged
from 70° (TCP), 43° (TCP +NH2
+) to 39° (TCP +NH2
+ + heparin)
provided evidence of surface modification. Addition of amine groups
and heparin demonstrated the relative hydrophilicity for each mod-
ification, where TCP +NH2
+ surfaces and TCP +NH2
+ + heparin sur-
faces were the most hydrophilic. These data are supported by Zhou
and Meyerhoff (2005), Liu et al. (2014), and Smith et al. (2016),
where contact angle decreases are reported for amine group and
heparin surface modification, respectively.
TABLE 1 Released concentration of NGF or BDNF from the bioactive surface at 1, 24, 48, and 168 hr
Released concentration (ng/ml) from bioactive surface/released percentage (%) from the total immobilized load
1 ng/ml 10 ng/ml 100 ng/ml 1 µg/ml
ng/ml % ng/ml % ng/ml % ng/ml %
NGF 1 hr 0 ± 0 0 0 ± 0 0 0 ± 0 0 0 ± 0 0
24 hr 0 ± 0 0 0.027 ± 0.054 1 0.044 ± 0.041 1 0.115 ± 0.146 0.03
48 hr 0 ± 0 0 0.002 ± 0.002 0.06 0.009 ± 0.019 0.04 0 ± 0 0
168 hr 0.004 ± 0.004 1 0 ± 0 0 0 ± 0 0 0 ± 0 0
BDNF 1 hr 0.075 ± 0 25 1.04 ± 0 35 9.35 ± 0 32 12.92 ± 0 3
24 hr 0.090 ± 0.008 30 0.083 ± 0.043 2.8 0.053 ± 0.074 0.18 0.043 ± 0.06 0.01
48 hr 0.033 ± 0.047 11 0.036 ± 0.050 1.2 0.108 ± 0.013 0.37 0.243 ± 0.18 0.06
168 hr 0.096 ± 0.003 31 0.043 ± 0.061 1.5 0.05 ± 0.071 0.17 0.049 ± 0.07 0.01
Note: This concentration is also presented as a percentage calculated from the initial immobilized neurotrophin load.
Abbreviations: BDNF, brain‐derived neurotrophic factor; NGF, nerve growth factor.
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F IGURE 3 Average neurite length grown over 7 days by chick embryo dorsal root ganglion (DRGs; E12) on TCP, NH2
+, and NH2
+ + heparin
surfaces in the presence of soluble (control) and immobilized surfaces (test) (a) cultured with NGF, (b) cultured with BDNF, and (c) cultured with
NGF plus BDNF. Bars = ±SD. (d) Average neurite length values. Three experiments were performed independently; three DRGs were seeded per
condition (N = 3 and n = 3). One‐way ANOVA with Tukey multiple comparison test was performed (*p < .05, **p < .01, ***p < .001, and
****p < .0001). ANOVA, analysis of variance; BDNF, brain‐derived neurotrophic factor; NGF, nerve growth factor; TCP, tissue culture
polystyrene
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We hypothesized that heparin binds electrostatically to surface
amine groups through attractive electrostatic force and have devel-
oped a glycosaminoglycan surface platform for growth factor deliv-
ery using heparin, through transient charge attraction of negative
functional groups and local release (WO 2017/017425 A1, 2017).
For this particular study, we employed a commercial BD PureCoat™
source of amine functional surfaces that arose from a prior study
(Robinson et al., 2012). This study precedes and underpins the ap-
plication reported herein. The amine coated plates were used to
fabricate the heparin + neurotrophin layers. This was the first step to
study the effectiveness of this delivery platform on neurite out-
growth. XPS analysis confirmed the presence of amine groups, and
separately the presence of sulfur for heparin at the modified surface.
This was paramount because to scale and apply this bioactive surface
to other biomaterials, we need to replicate the nitrogen content on
the commercially amine coated plates to replicate the results pre-
sented in this study. Therefore, we will aim to incorporate NH2
+
groups by plasma polymerization, as this process has effectively de-
posited amine groups in different materials (Beck et al., 2005; Dehili
et al., 2006; Smith et al., 2016). The formation of an NH2
+ + heparin
surface was used as a basis to permit NGF and BDNF immobilization
in the heparin layer, and a platform the study of enhanced neurite
outgrowth when in direct contact.
Studies have previously reported on chemically binding heparin
to coatings and scaffolds (Kim, Kang, Huh, & Yoon, 2000; Liu
et al., 2014; Zhou & Meyerhoff, 2005). Gigliobianco, Chong, and
Macneil (2015) bound heparin to alternate layers of poly-
ethyleneimine (positively charged) and heparin or polyethyleneimine
and polyacrylic acid by repeated rounds of electrostatic adsorption
using acrylic acid plasma deposition (known to have negatively
charged carboxyl groups; Campbell & Farrel, 2008). Their results
showed that heparin bound to alternate layers of polyethyleneimine
and acrylic acid. Moreover, heparin bound to positively charged
polyethyleneimine after seven layers of coating, whereas no heparin
was bound after five layers of coating (Gigliobianco et al., 2015). This
finding raises the question as to whether heparin could bind to other
positively charge functional groups, such as NH2
+. The atomic per-
centage of sulfur (found in heparin) present in seven layers of poly-
ethyleneimine was 0.53% (Gigliobianco et al., 2015). In comparison,
the present study demonstrated an atomic percentage of 0.69% for
sulfur on TCP +NH2
+ + heparin surfaces. This supported the hy-
pothesis that heparin was bound to the positively charged amine
groups at the surface.
Heparin is also known to bind growth factors (Meneghetti
et al., 2015; Sakiyama‐Elbert & Hubbell, 2000), including NGF and
BDNF (Sakiyama‐Elbert & Hubbell, 2000), albeit with moderate af-
finity. Considering these studies, we hypothesized that NGF and
BDNF would bind sufficiently through electrostatic and noncovalent
interactions, and with overall surface energy to immobilize. ELISA
analysis for each neurotrophin was used to investigate if the growth
factors were eluted over a timeframe consistent with nerve cell in-
teraction and growth at 1, 24, 48, and 168 hr. Results showed that
for each time point, the release was <35% of the total growth factor
immobilized onto the surface. Interestingly, surfaces immobilized
with NGF at 1 ng/ml did not show any release until Day 7 (168 hr).
This kinetic profile was of note and was hypothesized as advanta-
geous in regard to neural implant applications for repair, mapping
broadly to the initial stages of nerve repair following injury.
According to Roach, Eglin, Rohde, and Perry (2007), after im-
plantation of a biomaterial, water molecules form an intimate layer.
Proteins then adsorb on the material surface, and adherent cells that
express functionally binding integrins reach the surface and start to
interact with the protein layer. Thereafter, cells adhere, migrate, and
differentiate. This last step occurs from a few hours to a few days
after implantation. As functionalized surfaces containing immobilized
NGF at 1 ng/ml did not show any growth factor release between 1
and 48 hr, therefore, such a delivery platform could permit time for
neuronal cells to adhere to a regenerating guidance scaffold surface
before receiving stimuli from NGF at the surface to stimulate growth.
Chick embryo DRGs were cultured on surfaces containing im-
mobilized neurotrophins. Neurite development is shown in Figure 4.
DRGs were used for their accessibility and are comparable with
other model animal systems in regard to neurite regeneration (Kuhn,
Stoeckli, Condrau, Rathjen, & Sonderegger, 1991; Stoeckli
et al., 1989; Stoeckli, Kuhn, Duc, Ruegg, & Sonderegger, 1991). Sur-
faces with immobilized NGF at 1 ng/ml stimulated longest growth of
neurite in all groups. Neurite outgrowth was 18 times higher for
immobilized NGF (1 ng/ml) surfaces than negative TCP control sur-
faces. The response of DRGs on immobilized BDNF surfaces de-
monstrated a similar response, compared to immobilized NGF
surfaces, with 1‐ng/ml surfaces showing the largest response. Sur-
faces immobilized with NGF + BDNF at 100 ng/ml supported DRG
neurite lengths significantly longer than those on TCP negative
control surfaces, or TCP containing NGF at 1 µg/ml.
The different response of neurite outgrowth can be hypothe-
sized through activated second message pathways, following growth
factor binding to cell surface expressed membrane receptors. Both
NGF and BDNF bind to the tyrosine kinase receptors (Trk), TrkA and
TrkB, respectively (Madduri et al., 2009; Santos et al., 2016).
NGF–TrkA complexes are internalized at the neurite growth cones
and retrogradely transported to the soma, inducing microtubule and
actin polymerization, calcium influx, and organelle recruitment
(Kapur & Shoichet, 2004). However, when NGF–TrkA complexes are
not internalized, activation of the phosphatidylinositol 3‐kinase and
Akt/protein kinase B (PI3K/Akt) pathways arise, which regulate cell
survival and neurite extension (Gomez & Schmidt, 2007; Madduri
et al., 2009; Tang et al., 2013). When BDNF binds to TrkB receptors,
the PI3K/Akt pathway is triggered and microtubules are rearranged
to encourage filopodial elongation and lamellipodial formation
(Mcgregor & English, 2019). Hence, Trk receptors activate signaling
pathways which encourage neurite elongation in sensory and motor
neurons.
In DRGs, TrkA and TrkB receptors are expressed in the cell
membrane. However, the density of TrkB receptors is lower com-
pared to TrkA receptors (McMahon, Armanini, Ling, & Phillips, 1994).
Nevertheless, the expression of TrkB receptors is upregulated after
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injury (Santos et al., 2016). Hence, both NGF and BDNF are needed
to prevent cell death and to stimulate neurite outgrowth. The pre-
sent data would suggest that TrkB receptor expression is low, be-
cause neurite growth on immobilized BDNF surface was similar to
NGF immobilized surfaces. When NGF and BDNF were
coimmobilized, neurite length was not cumulative. This effect could
be related to the concentration of BDNF released from the surface,
since low doses of BDNF upregulate the expression of TrkB re-
ceptors, maximizing the effect of BDNF. In contrast, high doses
would be expected to downregulate the density of TrkB receptors.
F IGURE 4 Primary chick DRGs cultured on (a) Control, TCP, NH2
+, and NH2
+ + heparin in the presence of soluble NGF, BDNF, or
NGF plus BDNF. (b) Surfaces immobilized with NGF, BDNF, or NGF plus BDNF at different concentrations. β‐III‐tubulin is labeled in green.
Nuclei are labeled in blue. Scale bar = 500 µm. BDNF, brain‐derived neurotrophic factor; DRG, dorsal root ganglion; NGF, nerve growth factor;
TCP, tissue culture polystyrene [Color figure can be viewed at wileyonlinelibrary.com]
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Moreover, high doses of BDNF would inhibit neurite elongation
(Santos et al., 2016), whereas low doses of BDNF stimulate neurite
outgrowth in sensory neurons (e.g., DRGs). Thus, when delivered with
NGF, an equilibrium would be expected.
In summary, we report on the design, manufacture, physico-
chemical and biological characterization of surfaces immobilized with
NGF and BDNF using commercially amine coated plates and heparin.
NGF loaded surfaces at 1 ng/ml encouraged longest neurite lengths
due to (a) DRGs having sufficient time to attach to surfaces and (b)
neurotrophin release being controlled over a similar timeframe. DRG
neurites most likely formed via activation of PI3K through membrane
activation of NGF–TrkA. The system reported is relatively simple to
produce, and scalable for direct applications, using plasma poly-
merization, for enhancing the function of NGCs to enhance nerve
growth following acute injury.
5 | CONCLUSION
This study reports on the design and construction of bioactive sur-
faces with heparin bound electrostatically to amine groups, that can
be used to immobilize NGF and BDNF. The surface was used as a
model platform for delivery of NGF and BDNF. Bioactive surfaces
stimulated neurite outgrowth in DRGs using very low concentrations
of neurotrophin, making this approach directly applicable and scal-
able for improving the function of existing NGCs.
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